Physician profile
Audrey Brown
NPI 1124720107
$1,722.78
in general payments reported to CMS, 2019-2025
15 companies · $1,483 in 2025
The $1,483 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $102 · 2024: $138 · 2025: $1,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.21 |
| Education | $190.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $522.84 | 2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $293.61 | 2025 | Nemluvio |
| Organon LLC | $150.08 | 2025 | Vtama |
| Ucb, INC. | $137.23 | 2025 | Bimzelx |
| Leo Pharma INC. | $125.01 | 2025 | Anzupgo |
| Janssen Biotech, INC. | $94.99 | 2025 | Tremfya |
| Amgen INC. | $86.56 | 2023 | Repatha |
| Abbvie INC. | $78.41 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.73 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $40.63 | 2025 | |
| Merck Sharp & Dohme LLC | $40.51 | 2024-2025 | Verquvo |
| Abiomed | $30.21 | 2024 | Impella |
| Abbott Laboratories | $17.31 | 2024 | Merlin@Home |
| Novo Nordisk INC | $16.75 | 2024 | Ozempic |
| Pfizer INC. | $15.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.